Malondialdehyde can predict survival in hemodialysis patients
| Autor: | Diana Moldovan, Mirela Gherman Caprioara, Dan Vladutiu, Crina Rusu, Ioan Mihai Patiu, Alina Potra, Simona Racasan, Ina Maria Kacso |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
malondialdehyde
medicine.medical_specialty medicine.medical_treatment Gastroenterology survival chemistry.chemical_compound cardiovascular disease Statistical significance Internal medicine medicine oxidative stress Risk factor Original Research hemodialysis business.industry Proportional hazards model General Medicine Malondialdehyde medicine.disease Surgery Blood pressure chemistry Nephrology Cohort Hemodialysis business Kidney disease |
| Zdroj: | Clujul Medical |
| ISSN: | 2066-8872 1222-2119 |
| Popis: | Background and aims. Cardiovascular (CV) disease is the leading cause of morbidity and mortality in hemodialysis (HD) patients. Kidney disease is associated with increased oxidative stress (OS), a nontraditional CV risk factor. Few studies evaluate the effect of OS markers on CV events (CVE) and survival in HD patients. The aim of this study is to examine potential determinants of OS markers and their predictive role on survival and CV morbidity and mortality in HD patients during a long-term follow-up (108 months). Methods. We conducted an analytical cross-sectional prospective observational study, carried on a cohort of randomly selected HD patients. We registered in 44 HD patients baseline characteristics, OS markers, mortality and CVE over a period of 108 months and we used statistical analysis (descriptive, Kaplan-Meier, univariate and multivariate Cox model) for interpretation.Results. Bound malondialdehyde (bMDA) was positively correlated with serum calcium, protein carbonyls (PC) were inversely correlated with diastolic blood pressure (DBP) and directly correlated with ferritin, NOx was directly correlated with ceruloplasmin) and serum albumin. Of the measured OS markers only bMDA was related to survival (HR=3.29 95% CI (1.28-8.44), p=0.01), and approached statistical significance in the effect on CV mortality (HR=2.85 95% CI (0.88-9.22), p=0.07). None of the measured OS markers was associated with CVE.Conclusions. bMDA has a strong predictive value on survival in HD patients in a long-term follow-up (9 years). Its value is correlated with CV mortality but is not a predictor of CV events. Regular assessment of MDA in HD patients and the development of strategies aimed at reducing oxidative stress in these patients might be beneficial. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|